377 related articles for article (PubMed ID: 31450955)
1. Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases.
Rey F; Balsari A; Giallongo T; Ottolenghi S; Di Giulio AM; Samaja M; Carelli S
ASN Neuro; 2019; 11():1759091419871420. PubMed ID: 31450955
[TBL] [Abstract][Full Text] [Related]
2. Preconditioning-mediated neuroprotection through erythropoietin?
Dawson TM
Lancet; 2002 Jan; 359(9301):96-7. PubMed ID: 11809248
[No Abstract] [Full Text] [Related]
3. Neuroprotection in Neurodegenerative Disease: From Basic Science to Clinical Applications.
Monteiro MC; Coleman MD; Hill EJ; Prediger RD; Maia CS
Oxid Med Cell Longev; 2017; 2017():2949102. PubMed ID: 28337247
[No Abstract] [Full Text] [Related]
4. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells.
Weishaupt JH; Rohde G; Pölking E; Siren AL; Ehrenreich H; Bähr M
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1514-22. PubMed ID: 15111610
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor.
Pankratova S; Kiryushko D; Sonn K; Soroka V; Køhler LB; Rathje M; Gu B; Gotfryd K; Clausen O; Zharkovsky A; Bock E; Berezin V
Brain; 2010 Aug; 133(Pt 8):2281-94. PubMed ID: 20435631
[TBL] [Abstract][Full Text] [Related]
6. Erythropoiesis-stimulating protein delivery in providing erythropoiesis and neuroprotection.
Chang ZY; Chiang CH; Lu DW; Yeh MK
Expert Opin Drug Deliv; 2008 Dec; 5(12):1313-21. PubMed ID: 19040394
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of erythropoietin on Alzheimer's dementia model in rats.
Cevik B; Solmaz V; Yigitturk G; Cavusoğlu T; Peker G; Erbas O
Adv Clin Exp Med; 2017; 26(1):23-29. PubMed ID: 28397428
[TBL] [Abstract][Full Text] [Related]
8. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection and endocytosis: erythropoietin receptors in insect nervous systems.
Miljus N; Massih B; Weis MA; Rison JV; Bonnas CB; Sillaber I; Ehrenreich H; Geurten BR; Heinrich R
J Neurochem; 2017 Apr; 141(1):63-74. PubMed ID: 28142212
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin--a novel concept for neuroprotection.
Sirén AL; Ehrenreich H
Eur Arch Psychiatry Clin Neurosci; 2001 Aug; 251(4):179-84. PubMed ID: 11697582
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin: a neuroprotective agent in cerebral hypoxia, neurodegeneration, and epilepsy.
Merelli A; Czornyj L; Lazarowski A
Curr Pharm Des; 2013; 19(38):6791-801. PubMed ID: 23530506
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective properties of epoetin alfa.
Cerami A; Brines M; Ghezzi P; Cerami C; Itri LM
Nephrol Dial Transplant; 2002; 17 Suppl 1():8-12. PubMed ID: 11812906
[TBL] [Abstract][Full Text] [Related]
13. Faim2 contributes to neuroprotection by erythropoietin in transient brain ischemia.
Komnig D; Gertz K; Habib P; Nolte KW; Meyer T; Brockmann MA; Endres M; Rathkolb B; Hrabě de Angelis M; ; Schulz JB; Falkenburger BH; Reich A
J Neurochem; 2018 May; 145(3):258-270. PubMed ID: 29315561
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of ceftriaxone and erythropoietin on neuronal and behavioral deficits in an MPTP-induced animal model of Parkinson's disease dementia.
Huang CK; Chang YT; Amstislavskaya TG; Tikhonova MA; Lin CL; Hung CS; Lai TJ; Ho YJ
Behav Brain Res; 2015 Nov; 294():198-207. PubMed ID: 26296668
[TBL] [Abstract][Full Text] [Related]
16. Crocin may be useful to prevent or treatment of alcohol induced neurodegeneration and neurobehavioral sequels via modulation of CREB/BDNF and Akt/GSK signaling pathway.
Motaghinejad M; Safari S; Feizipour S; Sadr S
Med Hypotheses; 2019 Mar; 124():21-25. PubMed ID: 30798909
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research.
Sargin D; Friedrichs H; El-Kordi A; Ehrenreich H
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):573-94. PubMed ID: 21619868
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin as a neuroprotective agent.
Bell SG
Neonatal Netw; 2011; 30(2):135-9. PubMed ID: 21402522
[No Abstract] [Full Text] [Related]
19. Psychopharmacological neuroprotection in neurodegenerative disease: heuristic clinical applications.
Lauterbach EC; Shillcutt SD; Victoroff J; Coburn KL; Mendez MF
J Neuropsychiatry Clin Neurosci; 2010; 22(2):130-54. PubMed ID: 20463108
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus.
Nadam J; Navarro F; Sanchez P; Moulin C; Georges B; Laglaine A; Pequignot JM; Morales A; Ryvlin P; Bezin L
Neurobiol Dis; 2007 Feb; 25(2):412-26. PubMed ID: 17166730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
